GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PDS Biotechnology PDSB · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.08

-12.20%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About PDS Biotechnology

From its filings with the US Securities and Exchange Commission

SEC filings

PDS Biotechnology is based in Princeton, New Jersey and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker PDSB. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported a net loss of $34.5m. At that date it held total assets of $30.5m and shareholders' equity of $9.3m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
1 Oct 2015
Employees
21
Head office
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Incorporated in
DE
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Stephen GloverIndependent Chairman of the Board$114,074
  • Dr. Frank Bedu-AddoPresident, Chief Executive Officer, Director, since 2019$2.3m
  • Mr. Lars BoesgaardChief Financial Officer, Principal Accounting Officer and Principal Financial Officer
  • Mr. Stephan ToutainChief Operating Officer$939,788
  • Mr. Spencer BrownSenior Vice President, Compliance Officer, General Counsel, Corporate Secretary
  • Dr. Gregory ConnChief Scientific Officer$1.7m
  • Dr. Kirk ShepardChief Medical Officer$1.3m
  • Dr. Ilian IlievDirector$61,072
  • Ms. Kamil Ali-JacksonIndependent Director$84,574
  • Dr. Otis BrawleyIndependent Director$61,074
  • Mr. Gregory FreitagIndependent Director$83,574
  • Mr. Mike MoyerIR Contact Officer, since 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
41
Environment
43
Social
50
Governance
29
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • PDS Biotechnology Corp possesses several strengths that contribute to its success:

Weaknesses

  • While PDS Biotechnology Corp has numerous strengths, it also faces some weaknesses:

Opportunities

  • PDS Biotechnology Corp can leverage the following opportunities for further growth:

Threats

  • PDS Biotechnology Corp should be mindful of the following threats that could impact its growth and success:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.